PlumX Metrics
Embed PlumX Metrics

Pharmacokinetic considerations of regional administration and drug targeting: Influence of site of input in target tissue and flux of binding protein

Journal of Pharmacokinetics and Biopharmaceutics, ISSN: 0090-466X, Vol: 24, Issue: 4, Page: 369-387
1996
  • 10
    Citations
  • 0
    Usage
  • 4
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Hunt et al. introduced the concept of the Drug Targeting Index (DTI) to quantify tire gain associated with regional drug administration and targeting and showed that for tire ideal case of all drug first reaching the target DTI = 1 + CL(s)/(Qr(1 - E(T)) where CL(s) is the total clearance of drug from the body (including the target tissue), Q(T) is the target blood flow and E(T) is the steady-state extraction ratio of the drug in the target. In the model they portrayed the tissue as a homogeneous organ. A more general pharmacokinetic model has been developed that lakes into account the three anatomical spaces (vascular, interstitial, and intracellular) of the target organ or tissue and that, in addition to unbound drug permeating the vascular and cellular membranes, protein-bound drug can also flux between the vascular and interstitial spaces. Elimination of unbound drug can take place from the cellular and interstitial spaces. An important parameter influencing the DTI is shown to be the fraction of targeted dose that is eliminated there before it reaches the systemic circulation, f(T). Equations have been developed showing the relalionship between f(T) and E(T) and for DTI when drug is administered at the various sites within the tissue and under a variety of conditions. Only when drug is administered into the target arterial blood stream or when distribution of drug within the target tissue is perfusion rate-limited, does f(T) = ET and DTI = 1 + CL(s)/(Qr (1 - E(T)). Otherwise consideration needs to be given to tire permeabilities of both the unbound and bound drug and site of target administration, interstitial or intracellular. Their f(T) is greater than E(T) and DTI is greater than that expected had perfusion-rate limited distribution prevailed. The maximum benefit in DTI is seen for a drug of low cellular permeability but high cellular intrinsic clearance administered intracellularly.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know